Home Healthcare Market by Product (BP & Heart Rate Monitor, Ovulation Kit, HIV Test, ECG, Nebulizer, Hearing Aids, Pedometer, Cane, Crutches, Wheelchair), Software, Services (Rehabilitation, Pregnancy, Palliative), & Telehealth - Global Forecast to 2022
“The global home healthcare market projected to grow at a CAGR of 8.8%.”
The global home healthcare market is expected to reach USD 364.69 billion by 2022 from USD 239.30 billion in 2017, at a CAGR of 8.8%. Growth in this market is mainly driven by the growing geriatric population; increasing incidence of chronic diseases; and rising demand for affordable healthcare delivery systems due to increasing healthcare cost, technological advancements, and government initiatives to promote home healthcare. However, changing reimbursement policies, limited insurance coverage, and patient safety concerns are some factors that may hinder the growth of this market.
“Mobility care products are expected to grow at the highest CAGR during the forecast period.”
Based on product, the market is segmented into testing, screening, & monitoring products; therapeutic products; and mobility care equipment. The mobility care products segment is projected to register the highest CAGR of due to the growing geriatric population, ease of use, rising demand for personal independence, and social connectedness. These devices also offer personal security and safety.
“Skilled nursing services are expected to hold the largest share of the market in 2017.”
Based on service, the market is segmented into rehabilitation services, infusion therapy services, unskilled care services, respiratory therapy services, pregnancy care services, skilled nursing services, and hospice and palliative care services. The skilled nursing services segment is estimated to dominate the market. This can be attributed to the increasing geriatric population and rising incidence of chronic diseases.
“Clinical management software is expected to dominate the market during the forecast period.”
Based on software, the market is segmented into agency software, clinical management software, and hospice solutions. The clinical management software segment is estimated to hold the largest share of the home healthcare software market in 2017. This segment is expected to continue to dominate the market and register the highest CAGR. The main factor aiding this market’s growth is the need for automation in homecare management.
“Asia to witness the highest growth during the forecast period.”
In 2017, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. Factors such as rising geriatric population, increasing adoption of innovative techniques, increasing disposable income, expansion of home healthcare companies in the Asian region, rising awareness of home healthcare, and increasing need for affordable healthcare delivery systems are driving market growth in Asia.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 37%; Tier 2 - 41%; Tier 3 - 22%.
• By Designation: C-level- 29%; D-level- 25%; Others- 46%.
• By Region: North America-55%; Europe-24%; Asia-15%; RoW- 6%
List of companies profiled in the report
• Fresenius (Germany)
• GE Healthcare (US)
• Linde Group (Germany)
• McKesson Corporation (US)
• Roche (Switzerland).
• A&D Company (Japan)
• BAYADA Home Health Care (US)
• Almost Family (US)
• Abbott Laboratories (US)
• Amedisys (US)
• Kindred Healthcare (US)
• Kinnser Software (US)
• LHC Group (US)
• Omron Healthcare (Japan)
• Philips Healthcare (Netherlands)
The report provides an overview of the home healthcare market. It aims at estimating the market size and future growth potential of this market across different segments such as product, service, software, type of telehealth, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall home healthcare market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook